Alzheimer's disease drug development pipeline: 2018

INTRODUCTION: Treatments for Alzheimer's disease (AD) are needed due to the growing number of individuals with preclinical, prodromal, and dementia forms of AD. Drug development for AD therapies can be examined by inspecting the drug development pipeline as represented on clinicaltrials.gov. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Cummings, Jeffrey, Lee, Garam, Ritter, Aaron, Zhong, Kate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021548/
https://www.ncbi.nlm.nih.gov/pubmed/29955663
http://dx.doi.org/10.1016/j.trci.2018.03.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021548/
https://www.ncbi.nlm.nih.gov/pubmed/29955663
http://dx.doi.org/10.1016/j.trci.2018.03.009

Ejemplares similares